Inventor · disambiguated record
Zhigan Jiang
Also filed as: JIANG ZHIGAN
18 granted patents·5 pending applications·10 citations·filing 2014–2022
88Inventor score
Files withSHANDONG DANHONG PHARMACEUTICAL CO LTD5GUANGDONG RAYNOVENT BIOTECH CO LTD3MEDSHINE DISCOVERY INC3Heilongjiang zhenbaodao pharmaceutical co ltd2ZHANGZHOU PIEN TZE HUANG PHARM2
Top patents by PatentIndex Score
23 records- 0186US11053260B2Tri-cycle compound and applications thereofFUJIAN COSUNTER PHARMACEUTICAL CO LTD·Filed 2018·Granted Jul 6, 2021·4 cites·18 claims
- 0279US10526320B2Pyrrolidine derivatives as PPAR agonistsGUANGDONG RAYNOVENT BIOTECH CO LTD·Filed 2017·Granted Jan 7, 2020·2 cites·20 claims
- 0374US10647710B2Thiazole derivative and applications thereofMEDSHINE DISCOVERY INC·Filed 2018·Granted May 12, 2020·1 cites·21 claims
- 0468US9850251B2Imidazole derivative used as antiviral agent and use therof in preparation of medicamentSHANDONG DANHONG PHARMACEUTICAL CO LTD·Filed 2014·Granted Dec 26, 2017·1 cites·18 claims
- 0567US10717720B2Modified compound of andrographolideHeilongjiang zhenbaodao pharmaceutical co ltd·Filed 2016·Granted Jul 21, 2020·1 cites·13 claims
- 0667US10633347B2Crystal form B of 1-isobutyryl-1′-((1-(4,4,4-trifluorobutyl)-4,5,6,7-tetrahydro-1H-benzo[d]imidazol-2-yl)methyl)spiro[azetidine-3,3′-indolin]-2′-oneSHANDONG DANHONG PHARMACEUTICAL CO LTD·Filed 2019·Granted Apr 28, 2020·0 cites·10 claims
- 0765US10858322B2Process for preparing 1-isobutyryl-1′-((1-(4,4,4-trifluorobutyl)-4,5,6,7-tetrahydro-1H-benzo[D]imidazol-2-yl)methyl)spiro[azetidine-3,3′-indolin]-2′-oneSHANDONG DANHONG PHARMACEUTICAL CO LTD·Filed 2020·Granted Dec 8, 2020·0 cites·8 claims
- 0863US10160726B2Quinolone derivatives as antibacterialsNOVARTIS AG·Filed 2015·Granted Dec 25, 2018·1 cites·22 claims
- 0961US10227309B2Crystal form A of 1-isobutyryl-1′-((1-(4,4,4-trifluorobutyl)-4,5,6,7-tetrahydro-1H-benzo [d]imidazol-2-yl)methyl)spiro[azetidine-3,3′-indolin]-2′-oneSHANDONG DANHONG PHARMACEUTICAL CO LTD·Filed 2016·Granted Mar 12, 2019·0 cites·9 claims
- 1059US12492169B2Aminopyridine compound and application thereofCISEN PHARMACEUTICAL CO LTD·Filed 2021·Granted Dec 9, 2025·0 cites·16 claims
- 1159US11952388B2Crystal form of tri-cycle compound and application thereofFUJIAN AKEYLINK BIOTECHNOLOGY CO LTD·Filed 2019·Granted Apr 9, 2024·0 cites·16 claims
- 1258US11964969B2Crystal forms of thiazole compound and application thereofPHAENO THERAPEUTICS CO LTD·Filed 2019·Granted Apr 23, 2024·0 cites·18 claims
- 1357US11578081B1Crystal form as inhibitor of ACC1 and ACC2, and preparation method therefor and use thereofZHANGZHOU PIEN TZE HUANG PHARM·Filed 2020·Granted Feb 14, 2023·0 cites·8 claims
- 1457US2025326815A1Staple-containing polypeptides and application thereofSOTER BIOPHARMA PTE LTD·Filed 2022·Application pending·0 cites
- 1557US2024270810A1Preparation and application of polypeptideGUANGDONG RAYNOVENT BIOTECH CO LTD·Filed 2022·Application pending·0 cites
- 1656US11673899B2Crystal form of thieno[2,3-c]pyridazine-4(1H)-one compound, preparation method therefor and use thereofZHANGZHOU PIEN TZE HUANG PHARM·Filed 2020·Granted Jun 13, 2023·0 cites·5 claims
- 1754US11396493B2Amorphous pyrrolidine derivative as PPAR agonist and preparation method thereofGUANGDONG RAYNOVENT BIOTECH CO LTD·Filed 2018·Granted Jul 26, 2022·0 cites·5 claims
- 1854US2025121076A1Polypeptide drug conjugate having novel structure and application thereofMEDSHINE DISCOVERY INC·Filed 2022·Application pending·0 cites
- 1952US2024238281A1Piperazine derivatives and application thereofGUANGZHOU BAIYUNSHAN PHARMACEUTICAL HOLDINGS CO LTD BAIYUNSHAN PHARMACEUTICAL GENERAL FACTORY·Filed 2022·Application pending·0 cites
- 2051US11299482B2Salt and crystal form of modified andrographolide compound and preparation method thereofHeilongjiang zhenbaodao pharmaceutical co ltd·Filed 2018·Granted Apr 12, 2022·0 cites·7 claims
- 2149US2024067702A1Lactam-modified polypeptide compoundsDONGBAO PURPLE STAR HANGZHOU BIOPHARMACEUTICAL CO LTD·Filed 2021·Application pending·0 cites
- 2247US10030029B2Imidazole derivative used as antiviral agent and use thereof in preparation of medicamentSHANDONG DANHONG PHARMACEUTICAL CO LTD·Filed 2017·Granted Jul 24, 2018·0 cites·18 claims
- 2345US11680070B2Thieno[2,3-c]pyridazin-4(1H)-one derivative and application thereofMEDSHINE DISCOVERY INC·Filed 2019·Granted Jun 20, 2023·0 cites·20 claims
Join the waitlist — get patent alerts
Get an alert when Zhigan Jiang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →